Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carolina BioOncology Institute
Huntersville, North Carolina, United Statescarolinabiooncology.org ↗
- Ownership
- Private
- Employees
- ~32
- Development stage
- Phase 1
01
Overview
Carolina BioOncology Institute has conducted over 150 early phase immunotherapy clinical trials since its founding. It provides access to cutting-edge investigational treatments—especially first-in-human or early-phase cell therapies—for patients with advanced solid tumors. Its internal AACT cell therapy platform has shown high ex vivo tumor killing rates and plans to enter Phase I human testing by late 2025/early 2026. As a site for external sponsors’ programs like Qurgen’s SON-DP transcription factor inhibitor trial (Phase I), it contributes to safety/efficacy data generation across multiple indications.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyDendritic cell therapyTumor infiltrating lymphocyte therapyGene therapyAntibody-drug conjugate (radio-isotope conjugates)
- Industry
- Biotech
02
Partnerships
QurgenMultiple biopharmaceutical sponsors running phase I oncology/immuno-oncology/cellular/gene/radiologic agent studiesUNC Chapel HillDuke University
Beyond the preview
Go deeper on Carolina BioOncology Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Carolina BioOncology Institute.